By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Soleno Therapeutics  

1235 Radio Road
Suite 110
Redwood City  California  94065  U.S.A.
Phone: 1-650-213-8444 Fax: 1-650-213-8383


SEARCH JOBS

Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company is currently advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase II/III clinical development program during 2017. Soleno continues to market Capnia’s innovative medical devices, including the CoSense® End-Tidal Carbon Monoxide (ETCO) monitor, which measures ETCO and is used by hospitals to detect hemolysis in newborns, Serenz® Nasal Relief, an over-the-counter nasal allergy relief wash available in the US, and the NeoForce portfolio of neonatal pulmonary resuscitation solutions. It is expected that these products will be monetized and will not be a focus for the company in the long term.

YEAR FOUNDED:

1999

LEADERSHIP:

CEO: Anish Bhatnagar


Key Statistics


Email:
Ownership: Private

Web Site: Soleno Therapeutics
Employees:
Symbol: 
 



Industry
Pharmaceutical






Company News
//-->